Bauer, Jens http://orcid.org/0000-0003-3731-2385
Köhler, Natalie http://orcid.org/0000-0002-7502-0431
Maringer, Yacine http://orcid.org/0000-0002-2197-8740
Bucher, Philip http://orcid.org/0000-0001-7951-1580
Bilich, Tatjana
Zwick, Melissa
Dicks, Severin
Nelde, Annika http://orcid.org/0000-0001-8504-8481
Dubbelaar, Marissa http://orcid.org/0000-0002-4930-1467
Scheid, Jonas http://orcid.org/0000-0002-5923-1343
Wacker, Marcel http://orcid.org/0000-0002-8185-140X
Heitmann, Jonas S.
Schroeder, Sarah
Rieth, Jonas
Denk, Monika
Richter, Marion
Klein, Reinhild
Bonzheim, Irina http://orcid.org/0000-0002-7732-0788
Luibrand, Julia
Holzer, Ursula
Ebinger, Martin http://orcid.org/0000-0002-4229-8058
Brecht, Ines B.
Bitzer, Michael
Boerries, Melanie
Feucht, Judith
Salih, Helmut R. http://orcid.org/0000-0002-6719-1847
Rammensee, Hans-Georg
Hailfinger, Stephan
Walz, Juliane S. http://orcid.org/0000-0001-6404-7391
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (EXC2180 390900677)
Wilhelm Sander-Stiftung (2016.177.3)
José Carreras Leukämie-Stiftung (DJCLS 05 R/2017)
Else Kröner-Fresenius-Stiftung (2022_EKTP03)
Deutsche Krebshilfe (70114948)
Article History
Received: 29 July 2022
Accepted: 30 September 2022
First Online: 27 October 2022
Competing interests
: J.B., N.K., Y.M., M.Z., S.D., M. Boerries, and J.S.W. are listed as inventors on a patent related to the DNAJB1-PRKACA T cell epitopes and TCRs (Peptides and antigen binding proteins for use in immunotherapy against fibrolamellar HCC and other cancers, Application number: EP21214728.4). H.-G.R. is listed as an inventor on a patent related to the adjuvant XS15 (Adjuvant for the induction of a cellular immune response: DE102016005550.2). The other authors declare no competing interests.